Meeting
2015 Gastrointestinal Cancers Symposium
Molecularly-guided therapeutic options beyond tyrosine kinase inhibitors (TKIs) for gastrointestinal stromal tumors (GIST).
Authors
Rebecca Feldman
Caris Life Sciences, Phoenix, AZ
Rebecca Feldman , Zoran Gatalica , Sandeep K. Reddy , Sant P. Chawla , Kamalesh Kumar Sankhala
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Translational Research
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 58)
DOI
10.1200/jco.2015.33.3_suppl.58
Abstract #
58
Poster Bd #
B8
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2017 Gastrointestinal Cancers Symposium
Molecular characterization of squamous cell carcinoma of the anal canal (SCCA).
First Author: Benjamin Adam Weinberg
Poster
2014 ASCO Annual Meeting
Molecular profiling of 6,892 colorectal cancer patients to identify potential treatment options.
First Author: Wafik S. El-Deiry